SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bharat Parenterals - Quaterly Results

19 May 2026 Evaluate
Net sales declined -29.58%  to  Rs. 565.37 million from Rs. 802.84 millions.Net profit of the cmpany stood at Rs. 13.76 millions for the quarter ended March 2026 a decline of -39.75% from Rs. 22.84 millions  in the same quarter last year.The Operating Profit of the company witnessed a decrease to 44.78 millions from 68.53 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 565.37 802.84 -29.58 2340.15 3041.34 -23.06 2340.15 3041.34 -23.06
Other Income 44.44 22.58 96.81 125.52 145.48 -13.72 125.52 145.48 -13.72
PBIDT 44.78 68.53 -34.66 336.43 481.53 -30.13 336.43 481.53 -30.13
Interest 5.15 14.75 -65.08 34.35 47.85 -28.21 34.35 47.85 -28.21
PBDT 39.63 53.78 -26.31 302.08 433.68 -30.34 302.08 433.68 -30.34
Depreciation 20.38 18.22 11.86 83.65 70.52 18.62 83.65 70.52 18.62
PBT 19.25 35.56 -45.87 218.43 363.16 -39.85 218.43 363.16 -39.85
TAX 5.49 12.72 -56.84 58.24 98.62 -40.95 58.24 98.62 -40.95
Deferred Tax -4.42 -0.54 718.52 -11.34 -7.20 57.50 -11.34 -7.20 57.50
PAT 13.76 22.84 -39.75 160.19 264.54 -39.45 160.19 264.54 -39.45
Equity 68.92 68.92 0.00 68.92 68.92 0.00 68.92 68.92 0.00
PBIDTM(%) 7.92 8.54 -7.21 14.38 15.83 -9.20 14.38 15.83 -9.20

Bharat Parenterals Share Price

1369.00 -11.00 (-0.80%)
05-Jun-2026 10:12 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1792.25
Dr. Reddys Lab 1272.50
Cipla 1391.10
Zydus Lifesciences 1091.00
Lupin 2277.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×